Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Noutsias

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Herz|May 18, 2011
Treatment of cardiovascular diseases in cancer patientsM Noutsias, B Maisch
Herz|November 27, 2012
Cellular immune mechanisms in myocarditisM Noutsias, V J Patil, B Maisch
European Heart Journal|December 1, 1995
Immunohistochemistry in dilated cardiomyopathyU Kühl, M Noutsias, H P Schultheiss
MMW Fortschritte Der Medizin|May 17, 2002
[Myocarditis and dilated cardiomyopathy. New methods in diagnosis and therapy]M Noutsias, M Pauschinger, U Kühl, et al.
Journal of the American College of Cardiology|February 1, 1997
Cell-mediated cytotoxicity in hearts with dilated cardiomyopathy: correlation with interstitial fibrosis and foci of activated T lymphocytesC Badorff, M Noutsias, U Kühl, et al.
Circulation|April 27, 1999
Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathyM Noutsias, B Seeberg, H P Schultheiss, et al.
Heart (British Cardiac Society)|March 1, 1996
Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathyU Kühl, M Noutsias, B Seeberg, et al.
Herz|March 10, 2018
In HFREF patients, sacubitril/valsartan, given at relatively low doses, does not lead to increased mortality or hospitalization : A retrospective cohort studyR De Vecchis, C Ariano, G Di Biase, et al.
Herz|January 20, 2018
Sacubitril/valsartan for heart failure with reduced left ventricular ejection fraction : A retrospective cohort studyR De Vecchis, C Ariano, G Di Biase, et al.
Herz|February 17, 2018
Cognitive performance of patients with chronic heart failure on sacubitril/valsartan : A retrospective cohort studyR De Vecchis, C Ariano, G Di Biase, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Herz|May 18, 2011
Treatment of cardiovascular diseases in cancer patientsM Noutsias, B Maisch
Herz|November 27, 2012
Cellular immune mechanisms in myocarditisM Noutsias, V J Patil, B Maisch
European Heart Journal|December 1, 1995
Immunohistochemistry in dilated cardiomyopathyU Kühl, M Noutsias, H P Schultheiss
MMW Fortschritte Der Medizin|May 17, 2002
[Myocarditis and dilated cardiomyopathy. New methods in diagnosis and therapy]M Noutsias, M Pauschinger, U Kühl, et al.
Journal of the American College of Cardiology|February 1, 1997
Cell-mediated cytotoxicity in hearts with dilated cardiomyopathy: correlation with interstitial fibrosis and foci of activated T lymphocytesC Badorff, M Noutsias, U Kühl, et al.
Circulation|April 27, 1999
Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathyM Noutsias, B Seeberg, H P Schultheiss, et al.
Heart (British Cardiac Society)|March 1, 1996
Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathyU Kühl, M Noutsias, B Seeberg, et al.
Herz|March 10, 2018
In HFREF patients, sacubitril/valsartan, given at relatively low doses, does not lead to increased mortality or hospitalization : A retrospective cohort studyR De Vecchis, C Ariano, G Di Biase, et al.
Herz|January 20, 2018
Sacubitril/valsartan for heart failure with reduced left ventricular ejection fraction : A retrospective cohort studyR De Vecchis, C Ariano, G Di Biase, et al.
Herz|February 17, 2018
Cognitive performance of patients with chronic heart failure on sacubitril/valsartan : A retrospective cohort studyR De Vecchis, C Ariano, G Di Biase, et al.
Pageof 3